The expression of several key pro-survival components of BCR signaling was correlated with the expression of UGT2B17 in CLL patients, including BTK, BLNK, and ZAP70 among the most positively linked to UGT2B17 expression (Figure 1B). The gene discussed is UGT2B17; the disease is B-cell chronic lymphocytic leukemia.